Articles

  • 1 week ago | healthline.com | Gigen Mammoser

    Share on PinterestWegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo. Semaglutide had a favorable safety profile, with serious adverse events occurring at the same rate as placebo. Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a new clinical trial.

  • 3 weeks ago | healthline.com | Gigen Mammoser

    Share on PinterestVegans who meet their daily protein requirements may still fall short on certain essential amino acids, according to new research. The study highlights that protein quality, not just quantity, plays a critical role in meeting nutritional needs. Unlike animal-based proteins, many plant-based proteins are less digestible and may have lower concentrations of one or more essential amino acids.

  • 3 weeks ago | resources.healthgrades.com | Gigen Mammoser

    A new study estimates that CT scans could contribute to up to 5% of future cancer cases in the United States. Of the 62 million patients who received CT scans in 2023, approximately 103,000 are projected to develop cancer due to radiation exposure. Researchers identified “low value” or unnecessary scans and the lack of standardized radiation dosing as key contributors to increased cancer risk.

  • 4 weeks ago | resources.healthgrades.com | Gigen Mammoser

    Large language models (LLMs) are a potentially transformative healthcare technology, but concerns remain. New research indicates that LLMs may introduce bias in treatment recommendations based on sociodemographic factors. The study contributes to ongoing concerns among experts about the utility and accuracy of using LLMs in healthcare settings.

  • 1 month ago | healthline.com | Gigen Mammoser

    Share on PinterestTaking probiotics may reduce negative mood, according to a new clinical trial. The study adds more evidence to the gut-brain connection’s role in regulating emotion. Experts caution that probiotics are not a substitute for psychiatric medication and therapy. Probiotics reduced negative mood in a new clinical trial, adding to mounting evidence that the gut-brain connection plays a crucial role in mental health.